Extreme obesity with alveolar hypoventilation. Morbid (severe) obesity with alveolar hypoventilation
Conditions
Interventions
Intervention group: Patients who first time use BIPAP. The patients will use BIPAP device during sleep. The BIPAP device that will be used is RESMED lumis 100 (produced by RESMED company San Diego, Ca
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: BMI upper than 30 Arterial carbon dioxide upper than 45 Using BIPAP device for the first time
Exclusion criteria
Exclusion criteria: Asthma Obstructive Pulmonary Disease Heart Failure Pregnancy Using weight loss drugs Using Corticosteroids Drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Body water of patient. Timepoint: Begin of studying then one week, one month and six months. Method of measurement: With the help of Bioimpedance analyzer.;Body protein of patient. Timepoint: Begin of studying then one week, one month and six months. Method of measurement: With the help of Bioimpedance analyzer.;Body fat of patient. Timepoint: Begin of studying then one week, one month and six months. Method of measurement: With the help of Bioimpedance analyzer.;Blood PCO2 of patient. Timepoint: Begin of studying then one week, one month and six months. Method of measurement: Capnography.;Body Mass Index (BMI). Timepoint: Begin of studying then one week, one month and six months. Method of measurement: Using the balance, the weight of the patient will be measure and by using meter the height of patient will be measure.;O2 saturation. Timepoint: Begin of studying then one week, one month and six months. Method of measurement: Pulse Oximetery. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Babak Amra
Esfahan University of Medical Sciences
Outcome results
None listed